Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-05-02 to 2024-05-02
Current total value of award: $77.7
Description: 4564476036!ARTIFICIAL TEARS SOLU